FDA Brief

Warning letters Drugs

FDA warning letter to

Smart Women's Choice

High riskIssued May 19, 2021Posted May 25, 2021Center for Drug Evaluation and Research

FDA says Smart Women's Choice birth control cream is an unapproved new drug sold without FDA approval.

What happened

FDA reviewed the company's website from February to April 2021 and its Facebook and Instagram pages. FDA found the company took orders for Smart Women’s Choice and made claims that it prevents pregnancy and is safe and effective birth control. FDA said those claims make the product a drug and that it is an unapproved new drug.

What FDA found

  1. The product is intended to prevent pregnancy and affect body function, so FDA treats it as a drug.

    section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)
  2. FDA considers the product a new drug because it is not generally recognized as safe and effective for its claimed uses.

    section 201(p) of the FD&C Act, 21 U.S.C. 321(p)
  3. The company sells the new drug without an FDA-approved application.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. The company introduces or delivers the product for introduction into interstate commerce, which is prohibited for this unapproved new drug.

    section 301(d) of the FD&C Act, 21 U.S.C. 331(d)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the steps taken to fix the violations and prevent recurrence, with supporting documents. If it cannot finish in that time, it must explain why and give a completion date.

Who should pay attention

  • women considering non-hormonal birth control
  • retailers and distributors that sell contraceptive products
  • companies making similar birth-control claims online

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk